Asymptomatic pancreatic cyst treatment: UCLA-Veterans Affairs research team develops evaluation tool As a total consequence of improved imaging technology, pancreatic cysts are diagnosed in asymptomatic individuals who undergo scans for other reasons increasingly. And while many of these cysts stick to a benign course, a little but great number are either malignant during diagnosis or possess the potential to build up into pancreatic cancer throughout a patient’s lifetime. The problem for both individual and clinician is identifying which cysts to keep by itself and which to surgically remove. Today, a UCLA-Veterans Affairs analysis team is rolling out an evaluation device to help guidebook asymptomatic pancreatic cyst treatment.‘This brand-new collaboration complements our study initiatives in the renal disease space.’ AstraZeneca joins several biopharmas in establishing long-term medication discovery collaborations with Evotec-;including AZ’s have MedImmune subsidiary, with which usually Evotec includes a diabetes collaboration stretching back again to December 2010. Related StoriesMayo Clinic investigators discover novel system associated with diabetes riskDiabetes prevention starts in the wombStudy discovers high prevalence of dehydration in the elderly living in UK treatment homesEvotec has extra discovery alliances with companions offering Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, and Ono Pharmaceutical.